Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kelly

Showing results (31-40 of 253) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Vorinostat-Gateway to Epigenetic TherapyWm Kevin Kelly, Paul Marks, Victoria M Richon
Advances in Physiology Education|September 29, 2020
Degree requirements of physiology undergraduate programs in the Physiology Majors Interest GroupErica A Wehrwein, Valerie S VanRyn, Kevin Kelly
The Canadian Journal of Urology|August 23, 2011
New treatment options for castrate-resistant prostate cancer: a urology perspectiveLeonard G Gomella, Francisco Gelpi, William Kevin Kelly
Epilepsy & Behavior : E&B|January 31, 2004
Pharmacological outcomes in people with mental retardation and epilepsyKevin Kelly, Linda J Stephen, Martin J Brodie
JAMA Oncology|June 16, 2022
To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the EvidenceSusan Halabi, Bradley C Carthon, Wm Kevin Kelly
Molecular Ecology Resources|May 14, 2011
Development of a molecular diagnostic system to discriminate Dreissena polymorpha (zebra mussel) and Dreissena bugensis (quagga mussel)Marshal S Hoy, Kevin Kelly, Rusty J Rodriguez
Epilepsy & Behavior : E&B|December 8, 2004
Levetiracetam for people with mental retardation and refractory epilepsyKevin Kelly, Linda J Stephen, Martin J Brodie
Physician Executive|February 27, 2013
A results-driven risk management program: one surgical group's success storyJeffrey Cohen, Rocco Orlando, Kevin Kelly, et al.
Connecticut Medicine|June 13, 2012
Creating a culture of patient safety in a primary-care physician groupLenworth Jacobs, Karyl Burns, James Cox-Chapman, et al.
The Pharmacogenomics Journal|July 11, 2024
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertensionJulia C F Quintanilha, William Kevin Kelly, Federico Innocenti
Pageof 26

Showing results (31-40 of 253) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Vorinostat-Gateway to Epigenetic TherapyWm Kevin Kelly, Paul Marks, Victoria M Richon
Advances in Physiology Education|September 29, 2020
Degree requirements of physiology undergraduate programs in the Physiology Majors Interest GroupErica A Wehrwein, Valerie S VanRyn, Kevin Kelly
The Canadian Journal of Urology|August 23, 2011
New treatment options for castrate-resistant prostate cancer: a urology perspectiveLeonard G Gomella, Francisco Gelpi, William Kevin Kelly
Epilepsy & Behavior : E&B|January 31, 2004
Pharmacological outcomes in people with mental retardation and epilepsyKevin Kelly, Linda J Stephen, Martin J Brodie
JAMA Oncology|June 16, 2022
To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the EvidenceSusan Halabi, Bradley C Carthon, Wm Kevin Kelly
Molecular Ecology Resources|May 14, 2011
Development of a molecular diagnostic system to discriminate Dreissena polymorpha (zebra mussel) and Dreissena bugensis (quagga mussel)Marshal S Hoy, Kevin Kelly, Rusty J Rodriguez
Epilepsy & Behavior : E&B|December 8, 2004
Levetiracetam for people with mental retardation and refractory epilepsyKevin Kelly, Linda J Stephen, Martin J Brodie
Physician Executive|February 27, 2013
A results-driven risk management program: one surgical group's success storyJeffrey Cohen, Rocco Orlando, Kevin Kelly, et al.
Connecticut Medicine|June 13, 2012
Creating a culture of patient safety in a primary-care physician groupLenworth Jacobs, Karyl Burns, James Cox-Chapman, et al.
The Pharmacogenomics Journal|July 11, 2024
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertensionJulia C F Quintanilha, William Kevin Kelly, Federico Innocenti
Pageof 26